CBD gel shows promise for fragile x in Long-Term trial
Symptom relief
ENROLLING_BY_INVITATION
This study looks at the long-term safety of a CBD gel (ZYN002) applied to the skin for children, teens, and young adults with Fragile X syndrome. Participants apply the gel twice daily for 52 weeks. The goal is to see if the gel is safe and helps with symptoms over time.
Phase: PHASE2, PHASE3 • Sponsor: Zynerba Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 17, 2026 12:44 UTC